-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JjaicBR/Ty9qrKpE6ocib5pADLxb/6a6IVknge8k+d+5fghUhptc95OaGmAatLpk Z06De7gEEdyspmqFIP/jjQ== 0001140361-07-014971.txt : 20070731 0001140361-07-014971.hdr.sgml : 20070731 20070731170212 ACCESSION NUMBER: 0001140361-07-014971 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070730 FILED AS OF DATE: 20070731 DATE AS OF CHANGE: 20070731 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEWIS JEROME M CENTRAL INDEX KEY: 0001225855 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14732 FILM NUMBER: 071013338 BUSINESS ADDRESS: BUSINESS PHONE: 6174972070 MAIL ADDRESS: STREET 1: C/O ADVANCED MAGNETICS INC STREET 2: 61 MOONEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 6174972070 MAIL ADDRESS: STREET 1: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 3 1 doc1.xml FORM 3 X0202 3 2007-07-30 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001225855 LEWIS JEROME M C/O AMAG PHARMACEUTICALS, INC. 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140 0 1 0 0 VP of Scientific Operations Common Stock 19945 D Employee Stock Options (Right to Buy) 8.42 2013-08-12 Common Stock 625 D Employee Stock Options (Right to Buy) 10.87 2013-02-03 Common Stock 750 D Employee Stock Options (Right to Buy) 14.24 2014-08-03 Common Stock 1500 D Employee Stock Options (Right to Buy) 16.8 2015-02-01 Common Stock 2000 D Employee Stock Options (Right to Buy) 9.11 2015-11-15 Common Stock 3000 D Employee Stock Options (Right to Buy) 19.98 2016-02-07 Common Stock 12000 D Restricted Stock Units Common Stock 3000 D Mr. Lewis owns such shares jointly with his spouse. These options become exercisable on August 12, 2007. These options become exercisable on February 3, 2008. These options become exercisable in two equal installments on August 3, 2007 and August 3, 2008. These options become exercisable in two equal installments on February 1, 2008 and February 1, 2009. These options become exercisable in three equal installments on November 15, 2007, November 15, 2008, and November 15, 2009. These options become exercisable in three equal installments on February 7, 2007, February 7, 2008, and February 7, 2009. These restricted stock units vest in three equal installments on February 7, 2008, February 7, 2009, and February 7, 2010. Date is N/A. Price is N/A. /s/ Joseph L. Farmer, attorney-in-fact 2007-07-31 EX-24.1 2 poa1.htm POWER OF ATTORNEY Unassociated Document

POWER OF ATTORNEY
For Executing Forms 3, 4 and 5

Know all by these presents, that the undersigned hereby constitutes and appoints each of David Arkowitz and Joseph L. Farmer, signing singly, his true and lawful attorney-in-fact to:

 
(1)
execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of AMAG Pharmaceuticals, Inc. (the “Company”), Forms 3, 4 and 5 (including any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended and the rules thereunder;

 
(2)
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete the execution of any such Forms 3, 4 and 5 and the timely filing of such forms with the United States Securities and Exchange Commission and any other authority; and

 
(3)
take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in his discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or his substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.

This Power of Attorney replaces in their entirety any and all prior powers of attorney executed by the undersigned with respect to the subject matters set forth herein, including any powers of attorney previously filed with the Securities and Exchange Commission.  This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed this 25th day of July, 2007.



 
Signed: /s/ Jerome Lewis
 
Please Print: Jerome Lewis


 
 
 

 -----END PRIVACY-ENHANCED MESSAGE-----